Organized nation-wide implementation of sentinel lymph node biopsy in Denmark

Acta Oncologica

Volumn 47, Issue 4, 2008, Pages 556-560

  Friis, Esbern ^a   Galatius, Hanne ^b   Peter Garne, Jens ^c  

^a Rigshospitalet   (Denmark)

^b Hoersholm Hospital   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CENTER; CANCER STAGING; DENMARK; HUMAN; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SURGICAL TRAINING; SURGICAL WARD; BREAST TUMOR; FEMALE; LYMPH NODE METASTASIS; MASS SCREENING; METHODOLOGY; PATHOLOGY; STANDARD; UTILIZATION REVIEW;

BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASS SCREENING; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 45149123391     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802010732     Document Type: Article

References (14)

1. Christiansen P, Friis E, Balslev E, Jensen D, Møller S.Sentinel node biopsy in breast cancer, five years experience from Denmark. Acta Oncol 2008;47:561-68.
2. Lauridsen MC, Garne JP, Hessov I, Sørensen FB, Melsen F, Lernevall A, et al. Sentinel lymph node biopsy in breast cancer-the Aarhus experience. Acta Oncol 2000;39:421-2.
3. Ilum L, Bak M, Olsen KE, Kryh D, Berg V, Axelsson CK. Sentinel node localization in breast cancer patients using intradermal dye injection. Acta Oncol 2000;39:423-8.
4. Holck S, Galatius H, Engel U, Wagner F, Hoffmann J. False-negative frozen section of sentinel lymph node biopsy for breast cancer. Breast 2004;13:42-8.
5. Bass SS, Cox CE, Reintgen DS. Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am 1999;8:497-509.
6. Tafra L, McMasters KM, Whitworth P, Edwards MJ. Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg 2000;180:268-73.
7. McMasters KM, Wong SL, Chao C, Woo C, Tuttle TM, Noyes RD, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: A model for implementation of new surgical techniques. Ann Surg 2001;234:292-9; Discussion 299-300.
8. Cox CE, Bass SS, Boulware D, Ku NK, Berman C, Reintgen DS. Implementation of new surgical technology: Outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 1999;6:553-61.
9. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yaetman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-51.
10. Richards MA, Baum M, Dowsett M. Provision of breast services in the UK; the advantages of specialist breast units. Report of a Working Party of the British Breast Group. The Breast Supplement 1994.
11. Grabau DA, Jensen MB, Blichert-Toft M, Andersen JA, Dyreborg U, Carstensen B, et al. The importance of surgery and accurate axillary staging for survival in breast cancer. Eur J Surg Oncol 1998;24:499-507.
12. Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom (BASO). The BASO Breast Specialty Group. Eur J Surg Oncol Supplement 1998.
13. EUSOMA. The requirements of a specialist breast unit. Eur J Cancer 2000;36:2288-93.
14. Blichert-Toft M, Smola MG, Cataliotti L, O'Higgins N. Principles and guidelines for surgeons management of symptomatic breast cancer. Eur J Surg Oncol 1997;23:101-9.